Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy

Descripción del Articulo

Gastric cancer ranks fifth in both incidence and mortality worldwide, according to the report fromthe Global Cancer Observatory (Globocan) as of 2022 (1). When discussing the global gastric cancerreport, it is assumed that it refers to adenocarcinoma. However, it should be pointed out that themost f...

Descripción completa

Detalles Bibliográficos
Autores: Barreda Bolaños, Fernando, Medrano Palma, Enaida, Barreda Velit, Claudia, Quispe Cordova, Rita, Bravo Taxa, Mercedes del Pilar
Formato: artículo
Fecha de Publicación:2025
Institución:Universidad de San Martín de Porres
Repositorio:Horizonte médico
Lenguaje:español
OAI Identifier:oai:horizontemedico.usmp.edu.pe:article/3321
Enlace del recurso:https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321
Nivel de acceso:acceso abierto
Materia:Lymphoma
Adenocarcinoma
Stomach Neoplasms
Neoplasms, Second Primary
Linfoma
Neoplasias Gástricas
Neoplasias Primarias Secundarias
id REVHM_400adee4a369b4124904215679e50286
oai_identifier_str oai:horizontemedico.usmp.edu.pe:article/3321
network_acronym_str REVHM
network_name_str Horizonte médico
repository_id_str
dc.title.none.fl_str_mv Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy
Adenocarcinoma gástrico metacrónico luego de linfoma gástrico tratado con quimioterapia más radioterapia
title Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy
spellingShingle Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy
Barreda Bolaños, Fernando
Lymphoma
Adenocarcinoma
Stomach Neoplasms
Neoplasms, Second Primary
Linfoma
Adenocarcinoma
Neoplasias Gástricas
Neoplasias Primarias Secundarias
title_short Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy
title_full Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy
title_fullStr Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy
title_full_unstemmed Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy
title_sort Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapy
dc.creator.none.fl_str_mv Barreda Bolaños, Fernando
Medrano Palma, Enaida
Barreda Velit, Claudia
Quispe Cordova, Rita
Bravo Taxa, Mercedes del Pilar
author Barreda Bolaños, Fernando
author_facet Barreda Bolaños, Fernando
Medrano Palma, Enaida
Barreda Velit, Claudia
Quispe Cordova, Rita
Bravo Taxa, Mercedes del Pilar
author_role author
author2 Medrano Palma, Enaida
Barreda Velit, Claudia
Quispe Cordova, Rita
Bravo Taxa, Mercedes del Pilar
author2_role author
author
author
author
dc.subject.none.fl_str_mv Lymphoma
Adenocarcinoma
Stomach Neoplasms
Neoplasms, Second Primary
Linfoma
Adenocarcinoma
Neoplasias Gástricas
Neoplasias Primarias Secundarias
topic Lymphoma
Adenocarcinoma
Stomach Neoplasms
Neoplasms, Second Primary
Linfoma
Adenocarcinoma
Neoplasias Gástricas
Neoplasias Primarias Secundarias
description Gastric cancer ranks fifth in both incidence and mortality worldwide, according to the report fromthe Global Cancer Observatory (Globocan) as of 2022 (1). When discussing the global gastric cancerreport, it is assumed that it refers to adenocarcinoma. However, it should be pointed out that themost frequent histological types of gastric cancer are adenocarcinoma and lymphoma, the formerbeing the most frequent on average, accounting for over 95 % of all gastric neoplasms (2). In Peru, theLima Metropolitan Cancer Registry ranked gastric cancer as the third most frequent and the leadingcause of mortality for both sexes (3). On the other hand, the synchronous or metachronous diagnosisof these types of gastric cancer, such as adenocarcinoma and lymphoma, is rare. Metachronouscancer, or second primary cancer, is defined as a new tumor that occurs more than six months afterthe diagnosis of the first neoplasm, but is not caused by the dissemination or recurrence of theprevious tumor (4). For these reasons, and pertinently, we present the case report of a 57-year-oldfemale patient diagnosed with primary gastric lymphoma, treated with a combination of radiationtherapy and chemotherapy with curative intent. Thirteen years later, at the age of 70, she wasdiagnosed with gastric adenocarcinoma during a follow-up endoscopy, which was managed surgically.The case is detailed below, along with a review of the relevant literature.
publishDate 2025
dc.date.none.fl_str_mv 2025-03-17
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321
10.24265/horizmed.2025.v25n1.16
url https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321
identifier_str_mv 10.24265/horizmed.2025.v25n1.16
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321/2128
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321/2155
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321/2180
dc.rights.none.fl_str_mv Derechos de autor 2025 Horizonte Médico (Lima)
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2025 Horizonte Médico (Lima)
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/xml
text/html
dc.publisher.none.fl_str_mv Universidad de San Martín de Porres. Facultad de Medicina Humana
publisher.none.fl_str_mv Universidad de San Martín de Porres. Facultad de Medicina Humana
dc.source.none.fl_str_mv Horizonte Médico (Lima); Vol. 25 No. 1 (2025): Enero-Marzo; e3321
Horizonte Médico (Lima); Vol. 25 Núm. 1 (2025): Enero-Marzo; e3321
Horizonte Médico (Lima); v. 25 n. 1 (2025): Enero-Marzo; e3321
2227-3530
1727-558X
reponame:Horizonte médico
instname:Universidad de San Martín de Porres
instacron:USMP
instname_str Universidad de San Martín de Porres
instacron_str USMP
institution USMP
reponame_str Horizonte médico
collection Horizonte médico
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1841556169695428608
spelling Metachronous gastric adenocarcinoma following gastric lymphoma treated with chemotherapy and radiation therapyAdenocarcinoma gástrico metacrónico luego de linfoma gástrico tratado con quimioterapia más radioterapiaBarreda Bolaños, Fernando Medrano Palma, Enaida Barreda Velit, Claudia Quispe Cordova, Rita Bravo Taxa, Mercedes del Pilar LymphomaAdenocarcinoma Stomach Neoplasms Neoplasms, Second PrimaryLinfomaAdenocarcinomaNeoplasias GástricasNeoplasias Primarias SecundariasGastric cancer ranks fifth in both incidence and mortality worldwide, according to the report fromthe Global Cancer Observatory (Globocan) as of 2022 (1). When discussing the global gastric cancerreport, it is assumed that it refers to adenocarcinoma. However, it should be pointed out that themost frequent histological types of gastric cancer are adenocarcinoma and lymphoma, the formerbeing the most frequent on average, accounting for over 95 % of all gastric neoplasms (2). In Peru, theLima Metropolitan Cancer Registry ranked gastric cancer as the third most frequent and the leadingcause of mortality for both sexes (3). On the other hand, the synchronous or metachronous diagnosisof these types of gastric cancer, such as adenocarcinoma and lymphoma, is rare. Metachronouscancer, or second primary cancer, is defined as a new tumor that occurs more than six months afterthe diagnosis of the first neoplasm, but is not caused by the dissemination or recurrence of theprevious tumor (4). For these reasons, and pertinently, we present the case report of a 57-year-oldfemale patient diagnosed with primary gastric lymphoma, treated with a combination of radiationtherapy and chemotherapy with curative intent. Thirteen years later, at the age of 70, she wasdiagnosed with gastric adenocarcinoma during a follow-up endoscopy, which was managed surgically.The case is detailed below, along with a review of the relevant literature.El cáncer gástrico ocupa el quinto lugar tanto en incidencia como en mortandad a nivel mundial, según el reporte del Global Cancer Observatory (Globocan) al 2022 (1). Cuando se habla del reporte de cáncer gástrico a nivel internacional, se da por entendido que se refiere al adenocarcinoma; sin embargo, se debe precisar que las variedades histológicas más frecuentes del cáncer gástrico son el adenocarcinoma y el linfoma, siendo el primero el más frecuente en promedio, por encima del 95 % de las neoplasias gástricas en general (2). En el Perú, el Registro de cáncer de Lima Metropolitana ubicóal cáncer gástrico como tercero en frecuencia y como la primera causa de mortandad hablando de ambos sexos (3). Por otro lado, el diagnóstico sincrónico o metacrónico de estos tipos de cáncer gástrico, como el adenocarcinoma y el linfoma, es raro. El cáncer metacrónico, o segundo cáncer primario, se define como un tumor nuevo que ocurre más de seis meses después del diagnóstico de la primera neoplasia, pero que no es causado por una diseminación o recurrencia del tumor previo (4). Debido a estos motivos, y de forma pertinente, se presenta el reporte de caso de una paciente que presentó a los 57 años un linfoma gástrico primario, para el cual recibió tratamiento oncológico combinado de radioterapia y quimioterapia con intención curativa. Luego de 13 años, a los 70, es diagnosticada de adenocarcinoma gástrico durante un control endoscópico, el cual se manejó quirúrgicamente. Se detalla el caso a continuación, y se realiza una revisión de la literatura al respecto.Universidad de San Martín de Porres. Facultad de Medicina Humana2025-03-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/xmltext/htmlhttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/332110.24265/horizmed.2025.v25n1.16Horizonte Médico (Lima); Vol. 25 No. 1 (2025): Enero-Marzo; e3321Horizonte Médico (Lima); Vol. 25 Núm. 1 (2025): Enero-Marzo; e3321Horizonte Médico (Lima); v. 25 n. 1 (2025): Enero-Marzo; e33212227-35301727-558Xreponame:Horizonte médicoinstname:Universidad de San Martín de Porresinstacron:USMPspahttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321/2128https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321/2155https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3321/2180Derechos de autor 2025 Horizonte Médico (Lima)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:horizontemedico.usmp.edu.pe:article/33212025-03-17T20:10:26Z
score 13.432311
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).